Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Sex-Specific Differences in Low-Grade Glioma Presentation and OutcomeSurabhi Tewari, Martin C Tom, Deborah Y J Park, et al.Journal of Neuro-Oncology|May 13, 2025
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastasesAnirudh Bommireddy, Zachary S Mayo, Chandana A Reddy, et al.Journal of Neuro-Oncology|April 29, 2022
Cognitive function after concurrent temozolomide-based chemoradiation therapy in low-grade gliomasDeborah Y Park, Martin C Tom, Yanwen Chen, et al.Journal of Neuro-Oncology|June 21, 2023
18F-fluciclovine PET/CT to distinguish radiation necrosis from tumor progression for brain metastases treated with radiosurgery: results of a prospective pilot studyMartin C Tom, Frank P DiFilippo, Stephen E Jones, et al.Molecular Cancer|June 9, 2024
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancerRashmi Bharti, Goutam Dey, Debjit Khan, et al.International Journal of Radiation Oncology, Biology, Physics|August 29, 2019
Malignant Transformation of Molecularly Classified Adult Low-Grade GliomaMartin C Tom, Deborah Y J Park, Kailin Yang, et al.Journal of Neuro-Oncology|January 22, 2022
Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade gliomaDeborah Y Park, Martin C Tom, Wei Wei, et al.International Journal of Radiation Oncology, Biology, Physics|April 26, 2019
Risk Factors for Progression Among Low-Grade Gliomas After Gross Total Resection and Initial Observation in the Molecular EraMartin C Tom, Vamsi Varra, C Marc Leyrer, et al.Neuro-Oncology Advances|September 22, 2025
Guiding principles for adult CNS tumor treatment programsVincent Rock, Manmeet S Ahluwalia, Matt Anthony, et al.Science Translational Medicine|June 1, 2018
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistanceYu Shi, Olga A Guryanova, Wenchao Zhou, et al.Pageof 8